Basic Information
BAT STERILE SOLUTION FOR INJECTION
INJECTION, SOLUTION
Regulatory Information
SIN15749P
July 18, 2019
Prescription Only
Therapeutic
INTRAVENOUS
August 10, 2023
June 3, 2025
XJ06AA04
Company Information
EMERGENT SALES AND MARKETING SINGAPORE PTE. LTD.
EMERGENT SALES AND MARKETING SINGAPORE PTE. LTD.
Active Ingredients
Strength: > 600 U/vial
Strength: > 3300 U/vial
Strength: > 3000 U/vial
Strength: > 4500 U/vial
Strength: > 5100 U/vial
Strength: > 600 U/vial
Strength: > 3000 U/vial
Detailed Information
Contraindications
**4 CONTRAINDICATIONS** None.
Indication Information
**1 INDICATIONS AND USAGE** BAT \[Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)\] is a mixture of immune globulin fragments indicated for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes A, B, C, D, E, F, or G in adults and pediatric patients. The effectiveness of BAT is based on efficacy studies conducted in animal models of botulism.